Introduction
Hostile proximal infrarenal aortic neck is often considered one of the relative contra-indications for infrarenal endovascular aortic repair (EVAR), but large multicentre registries have shown that more EVARs have been performed worldwide beyond manufacturers' indications. [1] [2] [3] Data from the EUROSTAR Registry more than a decade ago looking at aneurysm morphology and procedural details of 2272 patients showed that perioperative New knowledge added by this study • Palmaz stenting is effective and safe as a salvage treatment of proximal endoleak during endovascular aortic repair (EVAR). Implications for clinical practice or policy • Appropriate patient selection, meticulous preoperative planning, and diligent follow-up ensured the ultimate success of EVAR. • A Palmaz stent should always be readily available during EVAR especially for aneurysms with a hostile aortic neck.
type 1a endoleak was significantly associated with a larger angulated infrarenal neck with thrombus. 4 Other morphological features included short aortic neck length, large sac diameter, severe angulation, and conical neck configuration. 5 Endoleak is defined as the persistence of blood flow outside the lumen of an endovascular graft but within an aneurysm sac. Type 1a endoleak is a leak around the proximal graft attachment site. They are clinically important since they can lead to continual aneurysm enlargement ORIGINAL ARTICLE of 16 (range, 1-59) months, none of the subsequent imaging showed a type 1a endoleak. The mean size of the aneurysm sac reduced from 7.4 cm preoperatively to 7.3 cm at 1 month, 6.9 cm at 6 months, 7.1 cm at 1 year, and 6.1 cm at 2 years postoperatively. None of these patients required aortic reintervention or had device-related early-or mid-term mortality. One patient required delayed iliac re-interventions for an occluded limb at 10 days post-surgery.
Conclusion:
In our cohort, Palmaz stenting was effective and safe in securing proximal sealing and fixation.
血管腔內主動脈瘤修復過程中使用近端修復 Palmaz支架置入來阻止血管滲漏的成效
結論：研究結果顯示Palmaz支架置入術在近端密封和固定的層面上是 安全和有效的。 and eventual rupture. 6 Although the development of renal and mesenteric fenestration or branched stent graft technology to extend the landing zone more proximally may overcome type 1a endoleaks, these devices may not be ideal because of regulations, complexity, and manufacturing delays. 7 In addition, contemporary published literature does not provide sufficiently strong evidence to warrant a change in treatment guidelines for juxtarenal or short-neck aneurysm. 8 The use of a proximal giant Palmaz stent (Cordis Corp, Fremont [CA], US) is a wellrecognised technique to manage a type 1a endoleak intra-operatively. [9] [10] [11] [12] A prophylactic Palmaz stent inserted for hostile neck has also been reported. [13] [14] [15] The aim of this study was to report the effectiveness and safety of an intra-operative Palmaz stent for an immediate type 1a endoleak.
Methods

Patient selection
Patients with an infrarenal abdominal aortic aneurysm (AAA) who had undergone EVAR were retrospectively reviewed for the period 1 July 1999 to 30 September 2015. Data were extracted from prospectively collected computerised departmental database, supplemented by patient records. This study was done in accordance with the principles outlined in the Declaration of Helsinki. All patients had undergone a preoperative fine-cut computed tomographic (CT) scan and careful preoperative planning with a conclusion that EVAR was feasible. All our patients who underwent EVAR had preoperative three-dimensional aortic anatomy examined using the stationary TeraRecon Aquarius workstation (TeraRecon, San Mateo [CA], US) that rapidly manipulates all preoperative data sets in the Digital Imaging and Communications in Medicine, and examines the aortic morphology. These details would be difficult to appreciate on twodimensional planar CT imaging, especially in those with inadequate short hostile neck. Those 
Proximal Palmaz stent placement
In the event of proximal endoleak on completion angiogram, further balloon molding would be attempted. Persistent endoleak was managed with balloon expandable giant Palmaz stent P4014 (Cordis Corp). Our preference was for the Palmaz stent to be positioned at the infrarenal region over the fabric of the stent graft, so as not to jeopardise any future chance of proximal extension with a renal or mesenteric fenestrated cuff. They would be crimped on a Coda balloon (maximum inflated diameter, 40 mm) and railed through a stiff guidewire to the top neck.
Preoperative aneurysm neck morphological analysis
Cause of proximal endoleak was usually hostile neck. We focused on aortic infrarenal neck anatomy where the Palmaz stent was placed and exerted its effect. All preoperative CT scans were analysed. Measurement was automatically calculated by computer software Aquarius iNtuition Client version 4.4 (TeraRecon Inc), after a median centre line path (MCLP) was drawn. We used definitions of neck measurement as defined by Filis et al 16 :
(1) Neck length is calculated between the point of MCLP at the orifice of the lower renal artery and MCLP at the start of the aneurysm. (2) Neck diameter is measured on the orthogonal cross-section of the neck, from the outer wall to the outer wall. It is measured at the lower renal artery level, 1 cm and 2 cm below. (3) Neck angle is the angle between the axis of the neck (straight line between the MCLP of the aorta at the level of the orifice of the lower renal artery and the MCLP of the aorta at the start of the aneurysm) and the axis of the lumen of the aneurysm (straight line between the MCLP at the start of the aneurysm and the MCLP at the end of the aneurysm). (4) Neck morphology (Fig 1) :
(a) Funnel shape is defined as 20% decrease in neck area between the level of the lower renal artery and 2 cm below. (b) Conical shape is defined as 20% increase in neck area between the level of the renal artery and 2 cm below. (c) Cylindrical shape is defined between the above two. (d) Shape is undetermined if neck length is less than 2 cm.
Clinical and radiological outcomes
Immediate radiological result following Palmaz stent placement was reported. Any procedural mortality or morbidity was recorded. Our departmental protocol recommends postoperative imaging, either CT scan or duplex scan, at 1 to 3 months, then every 6 months for the first 2 years, and annually thereafter. These were supplemented by X-ray to detect any stent fracture or migration. Any endoleak detected during follow-up was reported as well as any alteration in sac size. Follow-up was dated to the most recent objective imaging available.
Results
Patient population
During the study period Table 2 summarises the neck morphologies of our cohort. Morphological review of the pre-EVAR aneurysm neck showed five conical, one funnel, five cylindrical, and one undetermined short necks. The 
Analysis of aneurysm neck morphology
Radiological outcomes
All 12 patients had persistent proximal type 1a endoleak after stent graft placement with standard balloon molding. Placement of a giant Palmaz stent in the infrarenal position was technically successful in all cases, although one Palmaz stent was placed too low and lodged in one of the iliac limbs. Nonetheless, it served its function well in correcting the proximal endoleak (Figs 2 and 3) . Immediate resolution of the endoleak was achieved in eight (67%); whilst four (33%) had improved but persistent leak at completion of the procedure.
Clinical outcomes
After a median follow-up of 16 (range, 1-59) months, no patient had a type 1a endoleak on subsequent imaging, either CT scan or duplex ultrasound scan. All patients had at least one postoperative CT scan. Patient 2 had a type 1c endoleak from an embolised left internal iliac artery that was managed conservatively. Patients 9 and 11 had a type 2 endoleak, also managed conservatively. All had shrinkage of sac size. Sac size of the aneurysms decreased from a mean of 7.4 cm pre-EVAR to 7.3 cm, 6.9 cm, 7.1 cm, and 6.1 cm at 1 month, 6 months, 1 year, and 2 years post-EVAR, respectively (Fig 4) . Routine X-ray surveillance did not reveal any Palmaz stent fracture or migration. One patient required secondary endovascular re-intervention for occluded left iliac limb at day 10 postoperatively. It was due to a tortuous iliac system 
Discussion
Hostile aortic neck anatomy often precludes endovascular treatment of AAA. It has been shown in large clinical cohorts that up to 42% of EVARs are performed outside the instructions for use for commercially available stent grafts. 3, [17] [18] [19] Multiple measures have been developed to include more of these difficult necks for endovascular treatment.
Evolution of stent graft design including suprarenal fixation 20 and renal and mesenteric fenestration 21 are examples. Adjunctive neck measures, eg endostapling, 22, 23 proximal fibrin glue embolisation, 24 open aortic neck banding, 25 and proximal covered cuff extension 10 may be used in cases of perioperative type 1a endoleak following EVAR. Endostapling and glue embolisation, though minimally invasive, are not always feasible and risk major aortic injury. Open aortic neck banding requires laparotomy. Proximal cuff extension is only feasible if there is an additional sealing zone to the most caudal renal artery. Since we routinely landed our stent graft at the level of the lowest renal artery, this technique was not usually practical. The simplest and most well-recognised manoeuvre remains placement of a proximal Palmaz stent.
The morphology of the infrarenal aortic neck is important in securing the proximal landing zone. Three-dimensional workstation planning has been considered useful by many 26, 27 ; for example, Sobocinski et al 28 showed that it reduced the rate of type 1 endoleaks and Velazquez et al 29 indicated that it decreased the rate of extra iliac extension. We emphasise the importance of proper pre-EVAR planning, as this is one of the obvious factors that may compromise long-term durability and outcome. The fact that half of stent graft usage in our series was outside the instructions for use and most patients had one or more hostile neck feature rendered them at high risk of proximal endoleak. Under these circumstances, a Palmaz stent should always be readily available during EVAR.
Multiple series have reported their experience in its successful use. Early study by Dias et al 9 reported nine patients who received a Palmaz stent and in whom aneurysm remained excluded at a median follow-up of 13 months (range, 6-24 months). Rajani et al 10 reported successful treatment of intra-operative type 1 endoleak with Palmaz stent in 27 patients who had no recurrence at follow-up, although length of follow-up was not mentioned. Arthurs et al 11 reported no type 1 endoleak in 31 patients after a median follow-up of 53 months (interquartile range, 14-91 months). The Palmaz stent was effective across a variety of available devices with suprarenal fixation (eg Cook Zenith) or infrarenal fixation (eg Gore Excluder; WL Gore & Associates, Inc, Newark [DE], US). Our results are in agreement with these findings.
Other series have shown controversial 13 One (7%) patient had secondary endoleak with intervention after a mean follow-up of 12 months. Qu and Raithel 14 reported 117 cases of difficult neck treated with unibody Powerlink device (Endologix Inc, Irvine [CA], US). In this series, 83 (72.8%) had proximal Palmaz stent as an adjunctive procedure. Proximal cuff extension was also used. The mean follow-up was 2.6 years (range, 4 months-5 years). Results were satisfactory with an overall re-intervention rate of 5.3%, and no device migration, conversion, or post-EVAR rupture.
Palmaz stents were routinely placed at an infrarenal position in our unit on the basis that future extension with a fenestrated cuff is possible. If a transrenal position is adopted, the strut of the Palmaz stent, which is a very tight space, may hinder catheterisation of renal or visceral arteries should a fenestrated cuff be inserted. This is not absolute, however. Oikonomou et al 33 reported a case of posttreatment with Powerlink stent graft and transrenal Palmaz stent. Treatment of proximal endoleak at 3 years after operation was successful by means of a proximal fenestrated graft. Selective catheterisation of both renal arteries and dilation of the stent struts prior to stent graft repair ensured that it would be feasible to catheterise the renal arteries through the fenestrated cuff.
There are limitations to this study. The retrospective nature of our cohort may risk inaccurate information. The efficacy of the Palmaz stent in aneurysms with short infrarenal neck may not be tested, as the majority were considered straight for custom-made fenestrated or branched EVAR. In our limited experience, a Palmaz stent is a valuable tool to expand the boundary of endovascular treatment for AAA.
Conclusion
Palmaz stent helps proximal sealing and fixation. In our experience, Palmaz stenting is effective and safe as a salvage treatment of immediate proximal endoleak during EVAR. We emphasise the importance of appropriate patient selection, pre-EVAR planning, and diligent follow-up.
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